comorbidity of Psychological disorders in Patient with MS. Other specified mental disorders due to brain damage and dysfunction and to physical disease
Conditions
Interventions
Intervention 1: Intervention group:In this study, the Barlow unified protocol for transdiagnostic treatment method will be used.The sample size in this study is 45. They are randomly divided into two
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Suffering Ms disease with diagnosis of the neurological department Having a score of less than 5 in the (EDSS) Disability Indicator based on a neurologist's assessment to determine the individual's ability to attend a therapeutic session The age range is between 50 to 18 years old Affliction of emotional coexistence disorders including depression, anxiety and health anxiety based on diagnostic interview by psychologist Motivation and satisfaction for participation during treatment and research implementation Failure to receive psychological treatment in the past year Have at least a cycle of educationNot having other chronic diseases such as severe liver disorder The lack of current diagnosis of any mental disorder is consistent in Diagram 1 and 2 based on a psychologist's diagnostic interview, with the exception of emotional disorders including depression, anxiety and health anxiety No obvious risk of suicide now There is no history of drug abuse or dependence at the current time and within one year before the start of treatment
Exclusion criteria
Exclusion criteria: Unwillingness to attend research meetings Not attending at least 50% of the sessions Creating severe physical problems so that it can not be present at meetings
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comorbidity of psychological disorders of patients with MS. Timepoint: A week before the intervention, one week after the intervention, Three months after the intervention. Method of measurement: Beck Depression Inventory (BDI-II), Beck Anxiety Inventory, Short form Health Anxiety Scale (SHIA), Fatigue Exercise Scale (FSS), and Quality of Life Scale (MSQOL-54) questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Depression. Timepoint: A week before the intervention, one week after the intervention, three months after the intervention. Method of measurement: Beck Depression Inventory (BDI-II).;Anxiety. Timepoint: A week before the intervention, one week after the intervention, three months after the intervention. Method of measurement: Beck Anxiety Inventory.;Health Anxiety. Timepoint: A week before the intervention, one week after the intervention, three months after the intervention. Method of measurement: Short Form Health Anxiety Scale (SHIA).;Fatigue Severity. Timepoint: A week before the intervention, one week after the intervention, three months after the intervention. Method of measurement: Fatigue Severity Scale (FSS).;Quality of Life. Timepoint: A week before the intervention, one week after the intervention, three months after the intervention. Method of measurement: Multiple Sclerosis Quality of Life-54 (MSQOL-54). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactsasan amiri
Kermanshah University of Medical Sciences
Outcome results
None listed